Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Hold
13,921
0.43% 32
2026
Q1
$638K Buy
13,921
+647
+5% +$37.4K 0.27% 41
2025
Q4
$988K Buy
13,274
+729
+6% +$52.5K 0.42% 32
2025
Q3
$917K Buy
12,545
+246
+2% +$18.7K 0.42% 32
2025
Q2
$850K Buy
12,299
+35
+0.3% +$1.81K 0.42% 33
2025
Q1
$554K Buy
12,264
+259
+2% +$15.3K 0.29% 40
2024
Q4
$731K Sell
12,005
-255
-2% -$14.2K 0.39% 34
2024
Q3
$500K Buy
12,260
+589
+5% +$19.5K 0.27% 40
2024
Q2
$353K Buy
11,671
+676
+6% +$21.7K 0.2% 45
2024
Q1
$410K Buy
10,995
+2,144
+24% +$85.6K 0.24% 43
2023
Q4
$435K Sell
8,851
-975
-10% -$28.2K 0.27% 36
2023
Q3
$209K Buy
+9,826
New +$180K 0.14% 46

Other funds holding AFRM

MYeCFO's AFRM Position: Q2 2026 in Review

MYeCFO held its Affirm (AFRM) position steady in Q2 2026 at 13,921 shares worth $1.14M. The position accounts for 0.43% of the portfolio, ranked #32.

MYeCFO first reported a position in AFRM in Q3 2023 and has held it in 12 quarters since. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • MYeCFO held 13,921 shares of Affirm worth $1.14M as of Q2 2026.
  • MYeCFO left its Affirm share count unchanged in Q2 2026.
  • Affirm made up 0.43% of MYeCFO's portfolio in Q2 2026, its #32 holding.
  • MYeCFO first reported a position in Affirm in Q3 2023 and has held it in 12 quarters since.
  • 660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on MYeCFO's 13F filing for Q2 2026, filed 10 Aug 2026.